A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
about
Drug-eluting bead transarterial chemoembolisation for unresectable hepatocellular carcinomaDrug-eluting bead transarterial chemoembolisation for unresectable hepatocellular carcinomaTransarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and futureTransarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patientsInterventional therapies for hepatocellular carcinomaTransarterial therapy: an evolving treatment modality of hepatocellular carcinomaSystematic review of catheter-based intra-arterial therapies in hepatocellular carcinoma: state of the art and future directionsLocoregional drug delivery using image-guided intra-arterial drug eluting bead therapyTreatment of intermediate stage hepatocellular carcinoma: a review of intrahepatic doxorubicin drug-delivery systemsUpdate in management of hepatocellular carcinoma in Eastern populationDoes drug-eluting bead transcatheter arterial chemoembolization improve the management of patients with hepatocellular carcinoma? A meta-analysisAlginate Microspheres Containing Temperature Sensitive Liposomes (TSL) for MR-Guided Embolization and Triggered Release of DoxorubicinNew paradigm for management of hepatocellular carcinoma by imaging.Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial.Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinomaDevelopment of "imageable" beads for transcatheter embolotherapy.Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial.Comparison of DC Bead-irinotecan and DC Bead-topotecan drug eluting beads for use in locoregional drug delivery to treat pancreatic cancer.Embolotherapy in the management of hepatocellular carcinoma.Transarterial therapies for hepatocellular carcinoma.Transarterial chemoembolization with Doxorubicin-eluting microspheres for inoperable hepatocellular carcinoma.Transarterial chemoembolization using gelatin sponges or microspheres plus lipiodol-doxorubicin versus doxorubicin-loaded beads for the treatment of hepatocellular carcinomaTransarterial embolisation of hepatocellular carcinoma with doxorubicin-eluting beads: single centre early experience.Randomized comparison of selective internal radiotherapy (SIRT) versus drug-eluting bead transarterial chemoembolization (DEB-TACE) for the treatment of hepatocellular carcinoma.Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States.Systematic review comparing the safety and efficacy of conventional and drug-eluting bead transarterial chemoembolization for inoperable hepatocellular carcinoma.Doxorubicin-loaded drug-eluting beads versus conventional transarterial chemoembolization for nonresectable hepatocellular carcinomaOptimal technique and response of doxorubicin beads in hepatocellular cancer: bead size and dose.Hepatic arterial therapy with drug-eluting beads in the management of metastatic pancreatic carcinoma to the liver: a multi-institutional registry.Hepatic arterial therapy with drug-eluting beads in the management of metastatic bronchogenic carcinoma to the liver: a multi-institutional registry.Radiopaque drug-eluting beads for transcatheter embolotherapy: experimental study of drug penetration and coverage in swine.Transcatheter intraarterial therapies: rationale and overviewDC BeadM1™: towards an optimal transcatheter hepatic tumour therapy.Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trialNovel imaging biomarkers of response to transcatheter arterial chemoembolization in hepatocellular carcinoma patients.Transarterial Chemoembolization of Child-A hepatocellular carcinoma: drug-eluting bead TACE (DEB TACE) vs. TACE with cisplatin/lipiodol (cTACE)Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma?Transcatheter intra-arterial infusion of doxorubicin loaded porous magnetic nano-clusters with iodinated oil for the treatment of liver cancer
P2860
Q24187663-56C9EF3E-DB09-4343-9600-C8F593A22962Q24202061-8BB7AEEC-939E-49EE-B524-4DDE5ABE7793Q26771776-28BD5277-85E3-4A6B-8388-2CD2FB4DFADEQ26799469-10593EDA-2CDE-4450-99DE-47CF95975681Q26864803-8CADA58A-1DF3-4E94-9014-6A0580269387Q26866514-9A516D4C-373A-4FDC-BE57-5E9FF18DD5F5Q27007847-B526D337-C9E9-4245-A9B1-10860AAC7861Q27015918-790C2E25-EE28-4BC7-B479-C2853B24E544Q27025606-C8A4FE34-C3E4-4F9F-867A-0E24B2402FE1Q28080480-ABE038D5-AF0E-402C-AA5D-3AA932CC5B27Q28541480-CD94D96C-1280-4A00-A389-FF29BFD35BE1Q28550901-6B924C1D-91E2-44C9-BB25-AD63C38D65C9Q30448048-F897D021-8905-4B16-A4A9-815C254D20FEQ30468280-CB164B2C-1B40-4956-AA1C-12A94CE106A1Q33414645-EDA25DE1-D346-4285-A788-2F4EF42B5BDDQ33631372-25A89A8B-AC31-46B3-AA9F-1185F67C1F0BQ33718635-50EA0420-86B3-4C74-B090-E2A319707497Q33876358-CF291970-6189-4365-98E2-C433B27C74B5Q34045215-6F1DDD8F-E315-41BF-A36A-A84841BE275BQ34110928-3EFF4D5A-47B6-4313-B093-0B95E7A6C3FBQ34563655-41794C88-8C6D-4213-89B5-BFC5B534364CQ34628257-D73B3A6F-6B25-49A1-886E-5A586B865F5AQ34758857-192E3D0A-CDF8-4484-B396-8D1196BCFE83Q34975108-CFBF1DCE-14E7-47DA-9299-DD96DD4881A8Q34991857-9B0B0E0D-28D9-4D61-A52C-5F10EA324C90Q35164855-0C9F4206-0E13-4E30-8F40-E532EF9B18A6Q35322713-83C7DAB8-4D95-4403-9D7B-E3E2F9CB7428Q35411599-8E65726D-4BCC-41C0-9B65-1F600257FC22Q35682000-D7DD9714-698E-4092-83A2-1B0E78B71879Q35833080-7F764F14-7AC8-4602-A741-58B21044415AQ35837917-0BCFC2EC-627C-4A76-B191-A77F739C3E0BQ35864613-230B6639-946C-4A08-A0EE-A93B1198A736Q35988578-49499392-8FBC-4BF5-8361-D407888C1BBBQ36104314-B2DC210A-5BED-46C6-AC14-4E158AE97999Q36378569-655737AA-4503-4DFF-9323-7B181E33B895Q36383875-221F58D4-668F-41E0-8B39-58ED8E2C9877Q36419100-19300D62-4D99-489A-97C8-389A215ED619Q36516386-03D4819B-605D-4CA6-B90B-B75FDF920F47Q36573406-F485B1D5-BDF0-4152-BAC5-C179E80D855FQ36689688-AEF6EBBF-6E98-4E47-8274-FE3361A30B93
P2860
A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
A phase I/II trial of chemoemb ...... ra-arterial drug-eluting bead.
@en
A phase I/II trial of chemoemb ...... ra-arterial drug-eluting bead.
@nl
type
label
A phase I/II trial of chemoemb ...... ra-arterial drug-eluting bead.
@en
A phase I/II trial of chemoemb ...... ra-arterial drug-eluting bead.
@nl
prefLabel
A phase I/II trial of chemoemb ...... ra-arterial drug-eluting bead.
@en
A phase I/II trial of chemoemb ...... ra-arterial drug-eluting bead.
@nl
P2093
P1476
A phase I/II trial of chemoemb ...... ra-arterial drug-eluting bead.
@en
P2093
Kelvin K C Ng
Kin Shing Tai
Regina Woo
Roberta W C Pang
Ronnie T P Poon
Sheung Tat Fan
Wai Kuen Tso
P304
P356
10.1016/J.CGH.2007.04.021
P407
P577
2007-07-12T00:00:00Z